VINCENT RICHARD G — SEC insider filings

SEC reporting owner CIK 1269341. 17 insider filings on record with FilingPulse; latest filed 2026-08-27.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2021-02-16 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oncternal Therapeutics, Inc. (ONCT)Chief Financial Officer139 legs · 47,500 sh · $37,796—22
Forte Biosciences, Inc. (FBRX)Director4——6

Insider filings — VINCENT RICHARD G

FiledFormIssuerReported transactionsSource
2026-08-274Forte Biosciences, Inc. (FBRX)Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative)EDGAR
2026-06-024Forte Biosciences, Inc. (FBRX)Grant/award (A): 18,353 (derivative) @ $0EDGAR
2025-03-214Forte Biosciences, Inc. (FBRX)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2024-09-194Forte Biosciences, Inc. (FBRX)Grant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-154Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 14,200 (derivative) @ $0EDGAR
2024-01-054Oncternal Therapeutics, Inc. (ONCT)Tax withholding (F): 8,868 @ $0.50EDGAR
2023-10-044Oncternal Therapeutics, Inc. (ONCT)Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 35,120 (derivative) · Disposition to issuer (D): 280,000 (derivative) · Disposition to issuer (D): 109,579 (derivative) · Disposition to issuer (D): 28,750 (derivative) · Disposition to issuer (D): 210,000 (derivative) · +6 moreEDGAR
2023-07-054Oncternal Therapeutics, Inc. (ONCT)Tax withholding (F): 7,069 @ $0.36EDGAR
2023-04-144Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 30,000 @ $0.30EDGAR
2023-02-234Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 210,000 (derivative) @ $0EDGAR
2023-01-054Oncternal Therapeutics, Inc. (ONCT)Tax withholding (F): 4,428 @ $1.02EDGAR
2022-08-014Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 43,125 @ $0 · Grant/award (A): 28,750 (derivative) @ $0EDGAR
2022-03-284Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 3 @ $1.45 · Purchase (P): 356 @ $1.45 · Purchase (P): 5 @ $1.48 · Purchase (P): 2,136 @ $1.49 · Purchase (P): 2,500 @ $1.40EDGAR
2022-01-314Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 5,000 @ $1.80 · Purchase (P): 5,000 @ $1.70 · Purchase (P): 2,500 @ $1.65EDGAR
2022-01-244Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 109,579 (derivative) @ $0EDGAR
2022-01-054Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 29,867 @ $0EDGAR
2021-02-164Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 280,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1269341 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs